Clinic
The Brooklyn Hospital Center
The Brooklyn Hospital Center was paid $92.67M by Medicaid between Jan 2018 and Dec 2024, across 458 billing codes. Its largest line is 99215, doctor's office visit, returning patient (complex) — 10.0% of everything it billed.
33Billing provider infoTHE BROOKLYN HOSPITAL CENTER
BROOKLYN, NY 11201
BROOKLYN, NY 11201
33aNPI1326046467assigned 07/12/2005
33bProvider typeClinic/Center
28Total paid$92.67M
24GClaims2,009,733
24DCodes billed458
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in New York
Rank by total paid#2 of 235
Median peer was paid$630K
This provider vs. median147×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,959 | $896K | |
| 2019 | 154,591 | $5.32M | |
| 2020 | 365,123 | $12.82M | |
| 2021 | 428,074 | $16.68M | |
| 2022 | 378,686 | $25.06M | |
| 2023 | 373,428 | $20.04M | |
| 2024incomplete | 284,872 | $11.85M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 10.0% | 81,301 | 69,041 | $9.24M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.4% | 34,782 | 32,250 | $7.76M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.4% | 78,266 | 67,073 | $7.75M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.3% | 39,531 | 35,202 | $7.66M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.0% | 22,939 | 21,913 | $5.54M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4.1% | 8,483 | 3,240 | $3.79M |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 3.6% | 28,642 | 3,294 | $3.30M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.0% | 29,481 | 26,007 | $2.77M |
| 36415 | Collection of venous blood by venipuncture | 2.0% | 109,373 | 58,409 | $1.85M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.6% | 16,997 | 4,745 | $1.50M |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 1.2% | 1,301 | 877 | $1.13M |
| 99205 | Prolong outpt/office vis | 1.2% | 7,655 | 7,486 | $1.07M |
446 more codes
| 99285 | Emergency room visit (most serious) | 1.1% | 6,063 | $1.04M |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 34,329 | $982K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 7,469 | $959K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13,541 | $907K |
| 86850 | <1% | 14,546 | $877K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,101 | $853K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | <1% | 21,539 | $811K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 830 | $770K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 20,947 | $753K |
| A4657 | Syringe, with or without needle, each | <1% | 97,439 | $740K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 5,759 | $716K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,318 | $707K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 12,700 | $699K |
| G0378 | Hospital observation service, per hour | <1% | 857 | $687K |
| 80053 | Comprehensive metabolic panel | <1% | 34,269 | $683K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 8,714 | $646K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 3,630 | $622K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 22,618 | $621K |
| 87536 | <1% | 7,301 | $617K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 7,919 | $558K |
| 58558 | <1% | 333 | $548K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 5,985 | $513K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 6,551 | $504K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,200 | $475K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,172 | $468K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 6,861 | $449K |
| 99402 | <1% | 5,516 | $438K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 2,575 | $405K |
| 86480 | <1% | 6,860 | $393K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 4,199 | $386K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 11,121 | $359K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 35,182 | $354K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 5,943 | $349K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 4,129 | $347K |
| 88342 | <1% | 1,177 | $339K | |
| 76830 | Ultrasound, transvaginal | <1% | 5,735 | $335K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 4,500 | $320K |
| 90677 | <1% | 1,843 | $309K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 15,072 | $308K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 22,756 | $297K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,999 | $295K |
| 81025 | <1% | 13,328 | $291K | |
| 76818 | <1% | 4,126 | $270K | |
| 80061 | Lipid panel | <1% | 23,713 | $270K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,225 | $257K |
| 76641 | <1% | 4,611 | $255K | |
| Q3014 | Telehealth originating site facility fee | <1% | 6,217 | $242K |
| D1110 | Prophylaxis - adult | <1% | 5,740 | $239K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 4,528 | $233K |
| 86901 | <1% | 14,598 | $227K | |
| 83655 | <1% | 8,100 | $222K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 10,601 | $218K |
| G0277 | Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | <1% | 439 | $215K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 296 | $214K |
| 77066 | Tomosynthesis, mammo | <1% | 2,095 | $209K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 2,450 | $205K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 83,286 | $202K |
| D0330 | Panoramic radiographic image | <1% | 6,066 | $197K |
| 90686 | <1% | 13,358 | $186K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 3,292 | $181K |
| 90670 | <1% | 6,957 | $181K | |
| 99404 | <1% | 1,902 | $178K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 9,631 | $176K |
| D0120 | Dental checkup, returning patient | <1% | 6,839 | $174K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 16,302 | $170K |
| 88142 | <1% | 6,034 | $169K | |
| 99381 | <1% | 1,502 | $167K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,225 | $165K |
| 86900 | <1% | 14,603 | $163K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 5,393 | $158K |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 1,970 | $157K |
| 86360 | <1% | 3,275 | $154K | |
| 82310 | <1% | 49,648 | $149K | |
| 81003 | <1% | 24,140 | $148K | |
| 90651 | <1% | 3,469 | $145K | |
| 76813 | <1% | 2,236 | $141K | |
| 90715 | <1% | 5,379 | $140K | |
| 82947 | <1% | 24,426 | $138K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,287 | $134K |
| 90750 | <1% | 857 | $132K | |
| 93970 | <1% | 811 | $132K | |
| 80076 | <1% | 16,067 | $131K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 477 | $130K |
| 77065 | Tomosynthesis, mammo | <1% | 1,631 | $127K |
| 76770 | <1% | 1,044 | $124K | |
| 99442 | <1% | 1,897 | $118K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,933 | $118K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 740 | $118K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,537 | $112K |
| 99385 | <1% | 1,263 | $111K | |
| 19083 | <1% | 95 | $111K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 393 | $110K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,129 | $108K |
| 99401 | <1% | 1,395 | $108K | |
| 90461 | <1% | 4,601 | $107K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 10,413 | $107K |
| 90619 | <1% | 785 | $104K | |
| 82728 | <1% | 9,162 | $103K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 4,841 | $103K |
| 76536 | <1% | 1,448 | $100K | |
| 92250 | <1% | 2,120 | $96K | |
| 92551 | <1% | 2,645 | $95K | |
| 86769 | <1% | 3,246 | $92K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 3,428 | $92K |
| 76801 | <1% | 1,184 | $91K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 621 | $91K |
| 97162 | <1% | 994 | $90K | |
| J0606 | Injection, etelcalcetide, 0.1 mg | <1% | 10,561 | $90K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,886 | $86K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 992 | $84K |
| 83880 | <1% | 4,742 | $76K | |
| D0274 | Bitewings - four radiographic images | <1% | 3,517 | $76K |
| 97161 | <1% | 776 | $72K | |
| 0001A | <1% | 2,015 | $71K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 11,042 | $70K |
| 88307 | <1% | 551 | $69K | |
| D1120 | Dental cleaning, child | <1% | 1,707 | $68K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 22,984 | $68K |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 4,424 | $67K |
| 0002A | <1% | 1,826 | $67K | |
| 11045 | <1% | 230 | $67K | |
| 83735 | <1% | 19,092 | $66K | |
| 82607 | <1% | 5,685 | $65K | |
| 86803 | <1% | 10,480 | $64K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 8,271 | $63K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 50 | $63K |
| 86790 | <1% | 4,541 | $63K | |
| 90746 | <1% | 1,076 | $61K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 6,737 | $59K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 18,566 | $59K |
| 94726 | <1% | 762 | $57K | |
| 76642 | <1% | 1,441 | $55K | |
| 77062 | <1% | 1,643 | $54K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 251 | $54K |
| 77061 | <1% | 984 | $53K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 839 | $53K |
| D0367 | <1% | 196 | $52K | |
| 90682 | <1% | 1,430 | $52K | |
| 83037 | <1% | 4,701 | $52K | |
| 90698 | <1% | 6,649 | $51K | |
| 90680 | <1% | 5,229 | $51K | |
| 90707 | <1% | 4,258 | $51K | |
| 73620 | <1% | 3,254 | $50K | |
| 95115 | <1% | 1,613 | $50K | |
| 99386 | <1% | 574 | $50K | |
| 88341 | <1% | 434 | $49K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,015 | $48K |
| 99173 | <1% | 2,479 | $45K | |
| 83970 | <1% | 1,159 | $45K | |
| J1270 | Injection, doxercalciferol, 1 mcg | <1% | 12,777 | $45K |
| 99441 | <1% | 1,101 | $42K | |
| 93454 | <1% | 25 | $42K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,575 | $41K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 802 | $40K |
| 94010 | <1% | 551 | $40K | |
| 82803 | <1% | 3,036 | $39K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 4,556 | $39K |
| 81002 | <1% | 14,125 | $39K | |
| 86706 | <1% | 6,926 | $38K | |
| 90633 | <1% | 3,837 | $38K | |
| 90474 | <1% | 4,924 | $36K | |
| 97803 | <1% | 794 | $35K | |
| 86592 | <1% | 17,526 | $35K | |
| 0004A | <1% | 382 | $34K | |
| 84702 | <1% | 6,584 | $32K | |
| 83540 | <1% | 9,261 | $32K | |
| 86704 | <1% | 5,254 | $31K | |
| 72100 | <1% | 1,619 | $31K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,230 | $29K |
| 84100 | <1% | 18,802 | $29K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 120 | $29K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,951 | $29K |
| 87340 | <1% | 10,892 | $29K | |
| 29580 | <1% | 49 | $29K | |
| 85610 | <1% | 19,035 | $28K | |
| 84439 | <1% | 4,630 | $28K | |
| 83615 | <1% | 7,139 | $27K | |
| 83550 | <1% | 8,223 | $27K | |
| 90716 | <1% | 2,257 | $26K | |
| 90656 | <1% | 2,110 | $26K | |
| 87480 | <1% | 2,711 | $26K | |
| 90739 | <1% | 260 | $26K | |
| 86762 | <1% | 2,907 | $26K | |
| 82746 | <1% | 2,941 | $25K | |
| 90732 | <1% | 404 | $25K | |
| 0071A | <1% | 284 | $25K | |
| 82784 | <1% | 1,227 | $25K | |
| 85730 | <1% | 15,525 | $25K | |
| 94729 | <1% | 663 | $24K | |
| 73630 | <1% | 3,037 | $24K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 81 | $24K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 1,851 | $24K |
| 87510 | <1% | 2,714 | $24K | |
| 73610 | <1% | 2,165 | $23K | |
| 87660 | <1% | 2,713 | $23K | |
| 73562 | <1% | 2,135 | $23K | |
| 73030 | <1% | 1,796 | $23K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 13,224 | $22K |
| 81244 | <1% | 483 | $22K | |
| 10060 | <1% | 96 | $22K | |
| 73130 | <1% | 2,144 | $22K | |
| 86765 | <1% | 2,291 | $21K | |
| 84403 | <1% | 986 | $21K | |
| 93017 | <1% | 661 | $20K | |
| 90697 | <1% | 2,503 | $20K | |
| 0054A | <1% | 414 | $20K | |
| 70486 | <1% | 263 | $19K | |
| 88304 | <1% | 1,300 | $19K | |
| 81508 | <1% | 908 | $19K | |
| 90620 | <1% | 1,344 | $19K | |
| 86334 | <1% | 1,360 | $19K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 216 | $19K |
| 12011 | <1% | 54 | $19K | |
| 87088 | <1% | 7,351 | $19K | |
| 91320 | <1% | 206 | $18K | |
| 87522 | Neg quan hep c or qual rna | <1% | 578 | $18K |
| 0072A | <1% | 262 | $18K | |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | <1% | 38 | $18K |
| 97116 | <1% | 214 | $18K | |
| 86709 | <1% | 2,983 | $18K | |
| 87400 | <1% | 2,482 | $17K | |
| 86787 | <1% | 2,529 | $17K | |
| 87070 | <1% | 2,948 | $16K | |
| 84146 | <1% | 1,524 | $16K | |
| 20552 | <1% | 110 | $16K | |
| 76000 | <1% | 238 | $16K | |
| 86695 | <1% | 1,657 | $16K | |
| 86696 | <1% | 1,661 | $16K | |
| 90744 | <1% | 2,562 | $16K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 485 | $16K |
| 82043 | <1% | 4,159 | $15K | |
| 84550 | <1% | 5,128 | $15K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 1,159 | $15K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 953 | $15K |
| 97597 | <1% | 121 | $15K | |
| 90688 | <1% | 2,520 | $14K | |
| 15275 | <1% | 40 | $14K | |
| 90734 | <1% | 1,653 | $13K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 527 | $13K |
| 0052A | <1% | 240 | $13K | |
| 85045 | <1% | 5,114 | $13K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 49 | $13K |
| 97018 | <1% | 242 | $13K | |
| D1206 | Topical application of fluoride varnish | <1% | 448 | $13K |
| 82378 | <1% | 627 | $13K | |
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | <1% | 13 | $12K |
| 95117 | <1% | 287 | $12K | |
| 90696 | <1% | 1,565 | $12K | |
| 87625 | <1% | 300 | $11K | |
| 90658 | <1% | 1,270 | $11K | |
| 96367 | <1% | 209 | $11K | |
| 77080 | <1% | 415 | $11K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 165 | $11K |
| 83020 | <1% | 1,196 | $11K | |
| 86735 | <1% | 1,905 | $11K | |
| 83690 | <1% | 5,717 | $11K | |
| 84520 | <1% | 2,718 | $11K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 64 | $10K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,534 | $10K |
| 83605 | <1% | 3,739 | $10K | |
| 73110 | <1% | 997 | $9K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 25 | $9K |
| 90673 | <1% | 184 | $9K | |
| 71271 | <1% | 181 | $9K | |
| 0051A | <1% | 150 | $9K | |
| 82550 | <1% | 1,752 | $9K | |
| 86141 | <1% | 2,052 | $9K | |
| 91307 | <1% | 292 | $9K | |
| 71250 | <1% | 84 | $8K | |
| 87186 | <1% | 1,637 | $8K | |
| 83001 | <1% | 538 | $8K | |
| 80320 | <1% | 1,105 | $8K | |
| 0124A | <1% | 219 | $8K | |
| 36430 | <1% | 56 | $8K | |
| D4341 | <1% | 150 | $8K | |
| 90671 | <1% | 642 | $8K | |
| 77049 | <1% | 26 | $8K | |
| 84165 | <1% | 1,504 | $7K | |
| 88112 | <1% | 149 | $7K | |
| 80050 | General health panel | <1% | 264 | $7K |
| 99383 | <1% | 114 | $7K | |
| 81511 | <1% | 238 | $7K | |
| 99406 | <1% | 553 | $7K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 156 | $7K |
| 90480 | <1% | 232 | $7K | |
| 90681 | <1% | 940 | $6K | |
| 83010 | <1% | 694 | $6K | |
| 90740 | <1% | 56 | $6K | |
| 83002 | <1% | 401 | $6K | |
| 82248 | <1% | 1,303 | $6K | |
| 83521 | <1% | 795 | $6K | |
| 73502 | <1% | 416 | $6K | |
| 0003A | <1% | 68 | $5K | |
| 81243 | <1% | 489 | $5K | |
| 84153 | <1% | 1,037 | $5K | |
| 84481 | <1% | 999 | $5K | |
| 84450 | <1% | 1,234 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,365 | $5K |
| 72050 | <1% | 161 | $5K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 85 | $5K |
| 90662 | <1% | 245 | $5K | |
| 96415 | <1% | 18 | $5K | |
| 72131 | <1% | 51 | $5K | |
| 82955 | <1% | 292 | $4K | |
| 95819 | <1% | 14 | $4K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 928 | $4K |
| 84460 | <1% | 1,248 | $4K | |
| 82105 | <1% | 853 | $4K | |
| 99384 | <1% | 61 | $4K | |
| 72197 | <1% | 14 | $4K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,090 | $4K |
| 87280 | <1% | 529 | $4K | |
| 84480 | <1% | 1,035 | $4K | |
| 93320 | <1% | 1,624 | $4K | |
| 86705 | <1% | 651 | $3K | |
| 90649 | <1% | 188 | $3K | |
| 76820 | <1% | 176 | $3K | |
| 0053A | <1% | 37 | $3K | |
| 80074 | <1% | 64 | $3K | |
| 76870 | <1% | 50 | $3K | |
| 97802 | <1% | 74 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,629 | $3K |
| 82247 | <1% | 770 | $3K | |
| D9243 | <1% | 28 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 172 | $3K |
| 74018 | <1% | 424 | $3K | |
| 82570 | <1% | 905 | $2K | |
| D9430 | <1% | 114 | $2K | |
| 76857 | <1% | 83 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 85 | $2K |
| 85651 | <1% | 1,857 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,159 | $2K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $2K |
| 88313 | <1% | 1,168 | $2K | |
| D9239 | <1% | 28 | $2K | |
| 90685 | <1% | 362 | $2K | |
| 86580 | <1% | 235 | $2K | |
| 87901 | <1% | 13 | $2K | |
| 73080 | <1% | 232 | $2K | |
| D0160 | <1% | 41 | $2K | |
| 86665 | <1% | 126 | $2K | |
| 73564 | <1% | 74 | $2K | |
| 82565 | <1% | 1,028 | $2K | |
| 93325 | <1% | 1,609 | $2K | |
| Q4150 | Allowrap ds or dry, per square centimeter (add-on, list separately in addition to primary procedure) | <1% | 56 | $2K |
| 99443 | <1% | 31 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,932 | $1K |
| 86777 | <1% | 135 | $1K | |
| 86778 | <1% | 133 | $1K | |
| 85379 | <1% | 1,553 | $1K | |
| 84484 | <1% | 8,058 | $1K | |
| 90473 | <1% | 180 | $1K | |
| 73565 | <1% | 58 | $1K | |
| 87906 | <1% | 13 | $1K | |
| J3490 | Unclassified drugs | <1% | 1,044 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 70 | $1K |
| 87517 | <1% | 29 | $1K | |
| 90733 | <1% | 59 | $1K | |
| 0031A | <1% | 27 | $1K | |
| C1769 | Guide wire | <1% | 112 | $1K |
| 76821 | <1% | 17 | $992.75 | |
| 73590 | <1% | 240 | $977.70 | |
| D0272 | Bitewings - two radiographic images | <1% | 77 | $972.21 |
| 93971 | <1% | 12 | $916.35 | |
| 84425 | <1% | 64 | $865.76 | |
| 97165 | <1% | 12 | $849.58 | |
| 93923 | <1% | 14 | $833.25 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 180 | $826.12 |
| D0270 | <1% | 98 | $816.16 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,544 | $800.48 |
| 84132 | <1% | 718 | $763.85 | |
| 86003 | <1% | 138 | $619.03 | |
| 85384 | <1% | 265 | $595.21 | |
| 86038 | <1% | 157 | $595.18 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 11,203 | $574.00 |
| 87900 | <1% | 13 | $560.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 711 | $504.15 |
| 86780 | <1% | 77 | $503.92 | |
| 99382 | <1% | 13 | $488.00 | |
| 88311 | <1% | 166 | $487.21 | |
| D9310 | <1% | 12 | $450.69 | |
| 74019 | <1% | 66 | $437.92 | |
| 99001 | <1% | 733 | $431.49 | |
| 90687 | <1% | 17 | $426.42 | |
| 81000 | <1% | 140 | $384.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $383.52 |
| 87040 | <1% | 664 | $328.11 | |
| 84466 | <1% | 593 | $323.95 | |
| 82040 | <1% | 603 | $318.14 | |
| 82150 | <1% | 146 | $314.56 | |
| 87338 | <1% | 255 | $295.17 | |
| 90660 | <1% | 50 | $285.60 | |
| J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units | <1% | 14 | $273.24 |
| 96127 | <1% | 47 | $239.09 | |
| 86870 | <1% | 12 | $221.93 | |
| D1330 | <1% | 94 | $212.47 | |
| 90647 | <1% | 41 | $196.35 | |
| 80329 | <1% | 433 | $192.89 | |
| 84436 | <1% | 187 | $180.63 | |
| 90723 | <1% | 43 | $178.50 | |
| 86593 | <1% | 77 | $173.51 | |
| 73140 | <1% | 31 | $164.90 | |
| 86304 | <1% | 27 | $156.24 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,727 | $152.88 |
| 84075 | <1% | 600 | $151.77 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 127 | $151.70 |
| 83883 | <1% | 14 | $149.58 | |
| 82533 | <1% | 29 | $146.70 | |
| 73090 | <1% | 72 | $138.96 | |
| 82108 | <1% | 137 | $136.09 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 751 | $126.46 |
| 82668 | <1% | 13 | $125.10 | |
| 82374 | <1% | 578 | $116.82 | |
| 86880 | <1% | 12 | $114.99 | |
| 84295 | <1% | 584 | $114.65 | |
| G0008 | Administration of influenza virus vaccine | <1% | 153 | $114.53 |
| 80069 | <1% | 15 | $112.84 | |
| 82435 | <1% | 582 | $110.08 | |
| 86677 | <1% | 15 | $96.36 | |
| 84155 | <1% | 581 | $96.24 | |
| 90700 | <1% | 13 | $89.25 | |
| 99152 | <1% | 183 | $83.45 | |
| 87110 | <1% | 76 | $80.12 | |
| 82977 | <1% | 20 | $73.39 | |
| 86301 | <1% | 14 | $73.00 | |
| 90380 | <1% | 18 | $71.51 | |
| 90648 | <1% | 13 | $71.40 | |
| 82553 | <1% | 527 | $63.20 | |
| 83721 | <1% | 77 | $55.38 | |
| 86430 | <1% | 13 | $44.37 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 46 | $13.47 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 98 | $11.81 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 66 | $4.57 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 2,381 | $1.34 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 165 | $1.00 |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 48 | $0.34 |
| 99429 | 0% | 156 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 12 | $0.00 |
| 96376 | 0% | 13 | $0.00 | |
| 99080 | 0% | 3,389 | $0.00 | |
| A4649 | Surgical supply; miscellaneous | 0% | 236 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 165 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 13 | $0.00 |
| 82948 | 0% | 13 | $0.00 | |
| C1760 | Closure device, vascular (implantable/insertable) | 0% | 13 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFERREREAS, NELSON (VP OF REVENUE CYCLE)